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Sleep changes markedly across the life span and complaints
about insomnia are prevalent in older people [1]. Whether
age-related alterations in sleep are due to modifications in
social factors, circadian physiology, homeostatic drive, or
the ability to sleep remains unresolved. We assessed habit-
ual sleep duration at home and then quantified daytime sleep
propensity, sleep duration, and sleep structure in an inpa-
tient protocol that included extended sleep opportunities
covering 2/3 of the circadian cycle (12 hr at night and 4 hr
in the afternoon) for 3–7 days in 18 older and 35 younger
healthy men and women. At baseline, older subjects had
less daytime sleep propensity than did younger subjects.
Total daily sleep duration, which was initially longer than ha-
bitual sleep duration, declined during the experiment to
asymptotic values that were 1.5 hr shorter in older (7.4 6
0.4 SEM, hour) than in younger subjects (8.9 6 0.4). Rapid-
eye-movement sleep and non-rapid-eye-movement sleep
contributed about equally to this reduction. Thus, in the ab-
sence of social and circadian constraints, both daytime
sleep propensity and the maximal capacity for sleep are
reduced in older people. These data have important implica-
tions for understanding age-related insomnia.
Results
To assess age-related changes in maximal capacity for sleep
and in daytime sleep propensity, we studied 18 older subjects
(12 males, 6 females; age range 60–76 years; mean6 SD: 67.86
4.3 years) and 35 younger subjects (17 males, 18 females;
18–32 years; 21.9 6 3.3 years). The subjects were healthy
and had no sleep complaints or clinically significant sleep dis-
orders as assessed by a physical exam, medical history,
hematology, biochemistry, and a clinical polysomnogram.
Habitual Sleep Timing in Social Environment
We first assessed sleep patterns while the subjects were living
at home in their habitual social environment (data from one
subject in Figure 1). Older subjects showed an increased
‘‘morning’’ diurnal preference [2] (‘‘Owl-Lark’’ scores: older,
60.5 6 11.3 SD; versus younger, 51.3 6 8.5; p < 0.001), earlier
bedtimes (22:48 6 1:00 versus 0:24 6 1:12; p < 0.001), and
*Correspondence: ebklerman@hms.harvard.eduearlier wake times (6:54 6 1:00 versus 8:48 6 1:18; p <
0.001). Habitual sleep duration (HSD) (derived from self-report
and verified by actigraphy) varied considerably among individ-
uals: the observed range was 7.0–9.0 hr in older subjects and
6.1–10.3 hr in the younger (4 with HSD < 7.0 hr; 18 with 7.0 hr%
HSD % 9.0 hr [the same range as the older subjects]; 13
with HSD > 9.0 hr). There was no significant difference in
mean HSD between the groups: 8.16 0.6 hr for older subjects
and 8.5 6 1.0 hr for younger subjects.
Baseline Sleep Physiology and Daytime Sleep Propensity
We next assessed the physiological characteristics of sleep via
polysomnographic recordings in our inpatient facility (Figure 1).
For baseline sleep, bedtimes were scheduled at the same time
and duration as each subject’s assessed at-home schedule. In
accordance with previous studies, older subjects had signifi-
cantly less non-rapid-eye-movement (NREM) sleep stages 2
and 4, less rapid-eye-movement (REM) sleep, less total sleep
time (TST), and significantly more wake (Table S1 available on-
line). These age-related changes were also observed when we
compared those young and older people for whom HSD could
be matched, i.e., comparing all older subjects with the subset
of younger subjects for whom HSD fell between 7.0 and 9.0 hr.
To assess whether these age-related reductions in sleep
duration and sleep consolidation are accompanied by an
increase in daytime sleep propensity, we used the multiple
sleep latency test (MSLT), a validated tool widely used in clinical
practice [3]. Survivor-based statistical analysis revealed that
older subjects were less likely to fall asleep and if they did fall
asleep, took more time to do so than did younger subjects
(p = 0.009) (Figure 2A). The distribution of median MSLT results
was skewed to longer sleep latency times for older subjects (p <
0.001) (Figure 2B). In accordance with previous data on the
effects of sleep restriction on the MSLT [4–6], we found that
when the young sleepers were subdivided into three groups—
short sleepers (HSD < 7 hr), medium sleepers (7 < HSD < 9),
and long sleepers (HSD >9)—a gradual reduction on daytime
sleep propensity was observed (Figure 2C). MSLT values in the
older people remained significantly longer (p < 0.001) than those
in young people when matched for HSD (Figure 2C, middle).
Thus, in older subjects, who have less deep stage 4 sleep
and experience more awakenings during nighttime sleep, day-
time sleep propensity is lower than in young subjects who ex-
perience a much better polysomnographically determined
quality sleep. These data are contrary to the commonly held
belief that the reduced nighttime sleep quality in older people
would cause increased daytime sleep propensity. Other stud-
ies have reported increased sleep latencies (reflecting re-
duced daytime sleep propensity) during the MSLT in older
people [7, 8]. The current MSLT data may be interpreted as ei-
ther reflecting a reduced homeostatic drive for sleep in older
people or age-related reduction in the ability to initiate sleep.
‘‘Sleep need’’ relates to a homeostatic process with a set point
or equilibrium value. We assume that an individual has a set
sleep need and if that need is not met (condition of a sleep
debt), then (1) the person will sleep more when given additional
sleep opportunity; (2) the person will sleep until the sleep debt
is expressed and the person is at the homeostatic sleep
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homeostatic sleep equilibrium; and (4) at this equilibrium, day-
time sleep propensity and waking function are stable. A re-
duced sleep ability implies that changes in processes related
to sleep initiation and maintenance (e.g., increased arousal
[9] or neuroanatomic changes [10, 11]) prevent the individual
from meeting their sleep need. Although it is very difficult to
distinguish between these interpretations, we addressed this
issue by quantifying the time course of total sleep time (TST)
during extended daytime and nighttime sleep opportunities
for several days. Subjects had 16 hr of bedrest per 24 hr for
3–7 days (Figure 1) in the absence of time-of-day information:
12 hr at night and 4 hr in the afternoon, thereby including the
habitual time of afternoon naps, when the circadian timing sys-
tem has been reported to permit or facilitate sleep in particular
in older people. This protocol, with polysomnographically re-
corded sleep in darkness in a sound-attenuated room and in
the absence of time-of-day information, is designed to unmask
any endogenous sleep drive and thereby assesses any sleep
debt as well as the maximal capacity for sleep.
Sleep, Subjective Sleepiness, and Objective
Waking Performance
During the first day with extended sleep opportunity, both
younger and older subjects slept more than during the base-
line sleep episode and more than their HSD (p < 0.0001 for
both) (Figure 3B). This confirms that sleep duration is con-
strained by social or lifestyle factors. The initial rise, followed
by a decline in TST across days of extended sleep opportunity,
is evidence of the presence of sleep debt in most individuals.
This interpretation is supported by the changes in waking sub-
jective alertness and objective waking performance. After the
first nighttime 12 hr sleep episode, there were increases in
self-report of ‘‘alert’’ (p = 0.0001) and ‘‘fresh’’ (p = 0.0001)
Figure 1. Protocol and Sleep Times from One
Subject
Data are plotted in raster format in which time in
hours is plotted horizontally and day number is
plotted vertically; 2 consecutive days are pre-
sented on each row. The timing of sleep, as derived
from actigraphy and self-report while the subject
was at home, is indicated by open boxes. Inpatient
sleep episodes are indicated by black boxes and
multiple sleep latency tests by gray boxes. In the
present report, we include the data collected
through the sleep extension segment of the proto-
col; data from the second set of MSLTs and follow-
ing sleep episode are not included.
and decreases in the Karolinska Sleepi-
ness Scale (p < 0.0001) in younger and
older subjects. For objective measures,
there was significant and similar im-
provement in older and younger sub-
jects after the first nighttime 12 hr sleep
episode on two performance tasks: in-
creased number of calculations attemp-
ted (p < 0.0001) and scores on the digit
symbol substitution test (p < 0.0001),
but no changes in lapses in attention or
median reaction time on the psychomo-
tor vigilance test or other mood ratings
(data not shown). These data are consistent with the view
that self-selected HSD is less than optimal for daytime alert-
ness and functioning.
Asymptotic Duration of Sleep, NREM Sleep, and REM Sleep
Older people slept less than young people every day of the ex-
tended sleep opportunities (Table S2). To investigate whether
the two age groups would continue to differ if the experiment
were to be continued indefinitely, the dynamics and asymp-
totic values of sleep duration and sleep structure were esti-
mated by mixed model exponential-equation regression. The
asymptotic level for TST for older subjects was 7.4 hr (95%
C.I. 6.6–8.3 hr) and was achieved during the second 24 hr of ex-
tended sleep opportunity. The asymptotic value for TST for
younger subjects was 8.9 hr (C.I. 8.1–9.7 hr) (p = 0.009 versus
older) and was not achieved until approximately the fifth 24 hr
of extended sleep opportunity. For younger subjects with HSD
of the same ranges as the older subjects, the asymptote was
9.2 hr (C.I. 8.3–10.1 hr) (p = 0.005 versus older). Asymptotic
TST for the 12 hr nighttime sleep episodes also differed be-
tween the age groups, with older persons having less night-
time sleep (Figure 3A, Table 1). We also assessed the asymp-
totic duration for the various sleep stages. The 1.5 hr
difference in TST for nighttime plus daytime sleep was com-
posed ofw0.8 hr difference in REM sleep andw0.8 hr differ-
ence in NREM sleep. For the nighttime sleep opportunities,
the difference was also approximately equally composed of
changes in REM sleep and NREM sleep, although the time to
reach asymptotic level was longer for NREM sleep than for
REM sleep, the significance of which is not known.
Discussion
The amount of sleep required for maintaining alertness,
performance, and good health is a question asked by people
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1120of all ages. Many older persons complain of problems related
to the amount of sleep achieved, including problems falling
asleep at night, remaining asleep, and awakening too early in
the morning [12]. Studies have documented marked changes
across the life span with respect to the quantity and timing
of sleep, including self-reported decreased amounts of
Figure 2. Daytime Sleep Propensity as Assessed by the Multiple Sleep
Latency Test
(A) Survival curves of sleep latency, i.e., the percentage of subjects who are
awake for that wake duration or shorter, is plotted against elapsed time
during 20 min nap opportunities. Data of all five nap opportunities for
each subject are included.
(B) Histograms of percentage of older and younger subjects by median
sleep latency.
(C) Histograms of percentage of subjects by median sleep latency sepa-
rately for subjects with a habitual sleep duration less than 7 hr, between 7
and 9 hr, and greater than 9 hr. nighttime sleep, polysomnographically assessed reductions
in slow wave sleep (NREM sleep stages 3 and 4, SWS), and
increased daytime sleep (http://www.sleepfoundation.org/
site/c.huIXKjM0IxF/b.2417365/k.1460/2003_Sleep_in_America_
Poll.htm) [13]. Despite these well-documented age-related
changes in sleep, their interpretation continues to be
discussed. Current conceptual and physiological models of
sleep highlight the contribution of circadian processes and
Figure 3. Exponential Fit of Polysomnographically Recorded Sleep during
the Increased Sleep Opportunity
(A) Total sleep time (TST) during each day (E1–E7) of increased sleep oppor-
tunity, and during the 12 hr nighttime and the 4 hr daytime sleep opportunity
within each day.
(B) TST, rapid-eye movement (REM) sleep, and non-REM (NREM) sleep dur-
ing the baseline sleep episode (Day BL, shaded area) and during days E1–E7
for older (filled symbols) and younger (open symbols) subjects. The E1–E7
day symbols are mean and standard errors estimated by the fitted exponen-
tial function; the BL day symbols are the mean and standard error of poly-
somnographically recorded sleep.
Age-Related Reduction in Maximal Sleep Capacity
1121homeostatic factors, as well as social and lifestyle factors to
sleep duration [14, 15]. Identifying which interpretation best
reflects the processes underlying age-related phenomenolog-
ical changes in sleep is important because it will have an
impact on the approach taken to cope with and/or treat these
changes. For example, if sleep need does not decline with age,
the older person who sleeps only 6.5 hr per night is probably
sleep deprived. This is important because there is increasing
evidence that inadequate sleep is detrimental not only for
alertness and performance, but also for safety, immune and
metabolic function, learning, and other health outcomes
(e.g., [16–22]). Alternatively, if sleep need declines with age,
6.5 hr of polysomnographically confirmed sleep, which corre-
sponds to approximately 7–7.5 hr time in bed, may be ade-
quate for a 70-year-old healthy individual. Not recognizing
these age-related changes in sleep need may lead to self-se-
lecting a time in bed in excess of age-appropriate required
sleep duration, which in turn may contribute to complaints of
insomnia and difficulties falling asleep, remaining asleep, or
awakening too early.
Table 1. Asymptotic Duration of Sleep Measures in Young and Older












7.4 (0.4) 8.9 (0.4)** 9.2 (0.4)**
REM sleep (hr) 1.3 (0.1) 2.1 (0.1)*** 2.0 (0.1)***
All NREM
sleep (hr)
6.1 (0.3) 6.7 (0.4) 7.1 (0.4)*
NREM sleep
stage 1 (hr)
1.2 (0.2) N/A 1.4 (0.1)
NREM sleep
stage 2 (hr)
4.1 (0.4) 4.4 (0.4) 4.6 (0.4)
NREM sleep
stage 3 (hr)
0.6 (0.1) 0.5 (0.1) 0.5 (0.1)
NREM sleep
stage 4 (hr)
0.2 (0.1) 0.6 (0.1)*** 0.5 (0.1)**
SWS (hr) 0.8 (0.1) 1.1 (0.1)* 1.1(0.1)
Wake (hr) 8.5 (0.4) 7.0 (0.4)** 6.7 (0.4)
Nighttime (12 hr) Only
Total sleep
time (hr)
6.4 (0.3) 7.9 (0.2)*** 8.1(0.3)***
REM sleep (hr) 1.2 (0.1) 1.9 (0.1)*** 1.9 (0.1)***
All NREM
sleep (hr)
5.1 (0.2) 5.9 (0.2)** 6.2 (0.2)***
NREM sleep
stage 1 (hr)
1.0 (0.1) 1.1 (0.1) 1.1 (0.1).
NREM sleep
stage 2 (hr)
3.5 (0.2) 3.9 (0.3) 4.1 (0.2)
NREM sleep
stage 3 (hr)
0.5 (0.1) 0.4 (0.0) 0.4 (0.1)
NREM sleep
stage 4 (hr)
0.1 (0.1) 0.5 (0.1)*** 0.4 (0.1)***
SWS (hr) 0.7 (0.1) 0.9 (0.1)* 0.9 (0.1)
Wake (hr) 5.5 (0.3) 4.0 (0.2)*** 3.8 (0.3)***
Daytime (4 hr) Only
Total sleep
time (hr)
1.2 (0.2) N/A N/A
Data (6standard error) were fit to the equation: Sleep Measure = Asymptote +
b*exp(-(time constant)*day).
*p% 0.05; **p% 0.01; ***p% 0.001 for comparisons versus older. N/A indi-
cates no asymptote was statistically fit.The primary objective of our study was to assess changes in
sleep in healthy older people under conditions that allowed for
the assessment of maximal capacity for sleep in the absence
of lifestyle and circadian and environmental factors that might
compromise such an assessment. Many previous studies did
not adequately assess the health (including the presence of
sleep disorders or medical conditions or medications that
may affect sleep) of their older subjects, and many studies
used a standard 8 hr nighttime sleep opportunity to quantify
the age-related changes in sleep. Most previous studies
used protocols in which social and circadian constraints on
sleep were not minimized to the extent of our current protocol.
In accordance with many previous studies [23–26], our
baseline data show that healthy aging is accompanied by
changes in diurnal preferences, sleep timing, sleep duration,
NREM sleep, and REM sleep. Furthermore, baseline daytime
sleep propensity was reduced in older people: when matched
for HSD, younger people were more sleepy on the MSLT.
There are several possible reasons why older people have
longer sleep latencies than younger people during the
MSLT. (1) Older subjects might not be able to sleep during
the circadian day [7, 27] because of a ‘‘circadian wakeup’’
signal; therefore, daytime sleep propensity should not be
used as a proxy for sleep drive or sleep ‘‘need.’’ However,
the fact that older subjects had significant amounts of sleep
during the 4 hr sleep opportunities in this study argues
against this hypothesis. (2) Older subjects may have a lower
sleep need; therefore, despite a reduced nighttime sleep du-
ration, daytime sleep drive is lower in older than in younger
individuals. This latter interpretation is supported by the ob-
served reduction of asymptotic sleep duration in the older
people in this study. (3) Older subjects may have decreased
sleep ability, observed as more trouble initiating sleep or re-
maining asleep, because of increased arousal, similar to what
has been reported in insomnia [9], or because of neuroana-
tomic changes with aging [10, 11]. Although our data do
not allow us to distinguish between the latter two interpreta-
tions, the observation that in both age groups alertness im-
proved to a similar extent during the sleep extension phase
is in accordance with an age-related reduction in sleep need.
The initial increase in sleep duration when given extended
opportunity and the subsequent decline demonstrates that
both younger and older people carry a ‘‘sleep debt.’’ This sleep
debt dissipates with excess sleep and its duration reaches
asymptotic levels of 8.9 hr in the younger subjects and 7.4 hr
in older subjects. Because the reported time spent in bed
(HSD) while living in their normal environment was 8.5 hr in
the young individuals, it follows that young subjects do not al-
low themselves enough time to meet their asymptotic sleep
need. In the older subjects, HSD was 8.1 hr, which is in excess
of the 7.4 asymptotic total sleep duration; however, our base-
line polysomnogram data demonstrated that older subjects
sleep only approximately 6.5 hr during 8.1 hr time in bed,
and thereby also incur a sleep debt.
Previous studies have shown increased sleep, improved
subjective alertness, and objectively assessed performance
given increased opportunity in adolescents [28], college stu-
dents [29], and other young adults [30, 31]. These previous re-
ports and our current data are remarkably consistent with
respect to asymptotic sleep duration (>8 hr) and all suggest
habitual sleep durations obtained in the presence of social
and lifestyle constraints are less than the physiological set
point and that many individuals, young people in particular,
live with a ‘‘sleep debt.’’
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tion in younger and older adults who are given both nighttime
and daytime sleep opportunities with only minimal external
constraints on sleep duration. Under these conditions, there
was a reduction in both NREM and REM sleep in older persons
compared to young. This contrasts with results of studies in
which the sleep of young and older people was recorded while
time in bed was limited to 8 hr at night. These previous studies
have emphasized that aging primarily affects SWS only. Lon-
ger sleep opportunities or sleep at other circadian phases
[24, 25] may be necessary to observe changes in both NREM
and REM sleep. To what extent this change in both NREM
and REM sleep is associated with other age-related changes
such as neural plasticity and cognition remains to be estab-
lished. However, recognition that the maximal capacity for
sleep changes even during healthy aging may lead to novel ap-




Healthy older (target 60–80 years) and younger (target 18–30 years) men and
women were recruited to the study. None were recruited by reported HSD.
All were healthy by history, physical exam, electrocardiogram, and labora-
tory tests of blood and urine, and all passed a clinical sleep screen to verify
the absence of the clinical sleep disorders, sleep apnea, and nocturnal my-
oclonus. None were using any prescription or nonprescription medications.
None had worked night or rotating shifts in the past 3 years nor crossed
more than one time zone in the previous 3 months.
Procedures
The inpatient portion of the study was conducted in the Brigham and
Women’s Hospital General Clinical Research Center. The environment
was free of external time cues such as windows, clocks, radio, internet ac-
cess, TV, or nonstaff visitors. The protocol was approved by the Partners
Healthcare Institutional Review Board.
For 3 weeks prior to admission, study volunteers were instructed to ab-
stain from all medication, health food supplements, caffeine, tobacco,
and alcohol. Subjects were tested for the presence of these prohibited sub-
stances at least once during screening and again at inpatient admission. For
2 weeks, all self-selected sleep-wake times were reported in a daily diary
and telephone call-ins to a time-stamped machine. Though very few naps
were reported, they were included in further calculations. These self-se-
lected sleep-wake times were averaged to produce the schedule for the fol-
lowing week, which was also the week before admission and which included
only nighttime sleep episodes. The actual sleep and wake times, as deter-
mined by self-report, telephone call-in times, and wrist actigraphy, during
this last week were used to compute habitual sleep duration (HSD), which
was then used to schedule the timing and duration of the first nighttime
(baseline) sleep episode after admission. Note that in this report, HSD refers
to the time spent in bed; any wakefulness during this period is included.
Whereas it may be more accurate to refer to this measure as habitual bed-
rest duration, we use the term HSD because in healthy subjects the differ-
ence between the two measures is minor; most epidemiology studies use
the term sleep duration and in our protocol bedrest refers to extended sleep
opportunities. To be eligible for the inpatient portion of the study, subjects
needed to maintain the scheduled sleep time and wake time within 30 min;
subjects were allowed a maximum of two minor deviations from this sched-
ule (out of a total of 14 sleep and wake times in the last week before inpatient
study) and no naps for the last week before admission.
All inpatient events were scheduled relative to the subject’s HSD and
habitual bed and wake time. All inpatient sleep was recorded polysomno-
graphically. Subjects completed performance and alertness testing every
0.5–2 hr while awake (Supplemental Data). For their first inpatient night
(BL), all subjects were scheduled to sleep at the same time and of a duration
equal to their HSD. On the second inpatient day, subjects underwent a mul-
tiple sleep latency test (MSLT) protocol beginning 2 hr after awakening [32].
During each of five tests scheduled 2 hr apart within the MSLT, a subject is
instructed to lie quietly with eyes closed and try to fall asleep: latency to any
stage of sleep is reported. The subject is awakened when specific sleepcriteria are met. If the subject is still awake after 20 min, the test is termi-
nated. Subjects then began a schedule of 24 hr days with 16 hr of sleep op-
portunity: 12 hr centered at mid-habitual nighttime sleep episode and 4 hr
centered 12 hr opposite. By randomization, subjects participated in three
24 hr days of this schedule (9 younger subjects, 4 older); four 24 hr days
of this schedule (17 younger, 10 older); or seven 24 hr days of this schedule
(9 younger, 4 older).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and
two tables and are available at http://www.current-biology.com/cgi/
content/full/18/15/1118/DC1/.
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